DPhil @CompSciOxford @UniofOxford | Interested in personalised medicine and personalised dosing in clinical practice | Pharmacology | Maths | Stats | ML | AI
Interested in precision dosing, PKPD modelling, nonlinear mixed effects inference or Bayesian inference in general? Checkout our new publication in @PLOSCompBiol!
https://t.co/Fj2KY9QxCX
@PLOS@UKRI_News@EPSRC@CompSciOxford
Very happy to share that my new paper 'The Divisional Game: Using Procedural Rights to Impede Generic/Biosimilar Market Entry' has been published in the IIC. Available open access: https://t.co/RHHlV9bEbx
On which task-classes can different neural network architectures learn to generalise?
New research from our safety team shows that the Chomsky hierarchy successfully predicts out-of-distribution generalisation.
Paper: https://t.co/H26z1oxHBu
Code: https://t.co/xK45CgK5gd 1/
📣Excited our (@dav_aug) article on orphan drugs was published in the current issue of the European Intellectual Property Review. Analysing public records on orphan drugs from 2000–2020, as well as case law, we present two main findings. 1/3
🇺🇦 Can you help me make this post and photo BIG on Twitter? It’s @UniofOxford solidarity protest against the war since we #StandWithUkriane! Please follow @oxford_ukraine media to learn how may we help from the UK
Introducing MIA, a Multimodal Interactive Agent that cooperates and communicates with humans in a 3D virtual world called the Playhouse. MIA trains with imitation & self-supervised learning using 2.94 years of human experience https://t.co/SwG4nDoK9K
https://t.co/Yc0tFhblro 1/